OBJECTIVE: The objective of this study was to investigate whether self-efficacy is associated with physical, cognitive, and social functioning in individuals with multiple sclerosis (MS) when controlling for disease-related characteristics and depressive symptomatology. METHOD: Study subjects were 81 individuals between the ages of 29 and 67 with a diagnosis of clinically definite MS. Hierarchical regression analysis was used to examine the relationships between self-efficacy and self-reported physical, cognitive, and social functioning. RESULTS: Self-efficacy is a significant predictor of self-reported physical, cognitive, and social functioning in MS after controlling for variance due to disease-related factors and depressive symptomatology. CONCLUSIONS: Self-efficacy plays a significant role in individual adjustment to MS across multiple areas of functional outcome beyond that which is accounted for by disease-related variables and symptoms of depression. PsycINFO Database Record (c) 2014 APA, all rights reserved.
OBJECTIVE: The objective of this study was to investigate whether self-efficacy is associated with physical, cognitive, and social functioning in individuals with multiple sclerosis (MS) when controlling for disease-related characteristics and depressive symptomatology. METHOD: Study subjects were 81 individuals between the ages of 29 and 67 with a diagnosis of clinically definite MS. Hierarchical regression analysis was used to examine the relationships between self-efficacy and self-reported physical, cognitive, and social functioning. RESULTS: Self-efficacy is a significant predictor of self-reported physical, cognitive, and social functioning in MS after controlling for variance due to disease-related factors and depressive symptomatology. CONCLUSIONS: Self-efficacy plays a significant role in individual adjustment to MS across multiple areas of functional outcome beyond that which is accounted for by disease-related variables and symptoms of depression. PsycINFO Database Record (c) 2014 APA, all rights reserved.
Authors: Kathryn M Yorkston; Carrie M Kuehn; Kurt L Johnson; Dawn M Ehde; Mark P Jensen; Dagmar Amtmann Journal: Disabil Rehabil Date: 2008 Impact factor: 3.033
Authors: R Zivadinov; J Sepcic; D Nasuelli; R De Masi; L M Bragadin; M A Tommasi; S Zambito-Marsala; R Moretti; A Bratina; M Ukmar; R S Pozzi-Mucelli; A Grop; G Cazzato; M Zorzon Journal: J Neurol Neurosurg Psychiatry Date: 2001-06 Impact factor: 10.154
Authors: Dagmar Amtmann; Alyssa M Bamer; Karon F Cook; Robert L Askew; Vanessa K Noonan; Jo Ann Brockway Journal: Arch Phys Med Rehabil Date: 2012-05-07 Impact factor: 3.966
Authors: Hyewon Chung; Jiseon Kim; Ryoungsun Park; Alyssa M Bamer; Fraser D Bocell; Dagmar Amtmann Journal: Qual Life Res Date: 2016-04-26 Impact factor: 4.147
Authors: Barbara Seebacher; Roger J Mills; Markus Reindl; Laura Zamarian; Raija Kuisma; Simone Kircher; Christian Brenneis; Rainer Ehling; Florian Deisenhammer Journal: BMJ Open Date: 2019-08-20 Impact factor: 2.692